Flu prevention pill for household contacts
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether a single dose of an antiviral medicine (baloxavir marboxil) can prevent the flu in people who live with someone who has the flu. It's designed for household contacts who are not yet sick but have been exposed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a household contact of someone who has the flu, not currently sick yourself.
- You must have lived with the person who has the flu for at least 48 hours before joining.
- You must not have been diagnosed with the flu this flu season already.
- You must not be immunocompromised or taking certain medications (like steroids or immune-suppressing drugs).
- You must be willing to stay living with the infected person until Day 10 of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests a new medication, sebaloxavir marboxil, to see if it can prevent the flu in people who live with someone who has the flu. If you qualify, you would take the study drug and be monitored for a few weeks.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
This study tests two flu medicines, oseltamivir and baloxavir marboxil, to see if they can prevent flu in people who are in the hospital and were exposed to someone with the flu. It may help you avoid getting sick while you are in the hospital.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
Hear when a new Influenza, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.